Regulatory
Brokers Asked to Suspend Margin Loans for CENTRALPHL Shares
Brokers and merchant bankers were asked to stop providing margin-loan facilities for purchases of CENTRALPHL shares from 1 January 2019.
CENTRALPHLPharmaceuticals & Chemicals
Follow the latest news and corporate disclosures of Central Pharmaceuticals Limited (DSE: CENTRALPHL), including board meetings, quarterly financial results, dividend decisions, record dates, AGM notices and regulatory updates.
Brokers and merchant bankers were asked to stop providing margin-loan facilities for purchases of CENTRALPHL shares from 1 January 2019.
CENTRALPHL moved from A category to B category effective 1 January 2019.
CENTRALPHL published a corporate disclosure on 5 December 2018. Read the full announcement for details.
CENTRALPHL published a corporate disclosure on 5 December 2018. Read the full announcement for details.
CENTRALPHL published a corporate disclosure on 25 November 2018. Read the full announcement for details.
CENTRALPHL published a corporate disclosure on 22 November 2018. Read the full announcement for details.
CENTRALPHL published a corporate disclosure on 19 November 2018. Read the full announcement for details.
CENTRALPHL published a corporate disclosure on 15 November 2018. Read the full announcement for details.
CENTRALPHL will hold a board meeting on 14 November 2018 at 2:45 PM.
CENTRALPHL published a corporate disclosure on 28 October 2018. Read the full announcement for details.